More sophisticated single-use 2D biocontainers for pharmaceutical manufacturing.
The "Allegro(TM) 2D Biocontainer" is made from high-quality film that meets the performance and specifications required in the fields of biotechnology and pharmaceutical manufacturing. As part of a wide range of offerings, capacities are available from 50mL to 50L. It is equipped with various features necessary for single-use systems, including a sample port standard on all sizes, large-diameter ports for sensor installation, and compatibility with a variety of tube sizes to match process flow rates. 【Features】 ■ Shape that allows for efficient fluid discharge ■ Capable of filling to the specified capacity (full) even for applications requiring freezing ■ Inlet and outlet options available in 1/4 to 1/2 inch ■ Sensors can be inserted through the 1/2 inch port ■ Ports designed for connection with cable ties or BarbLock *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Other Features】 ■ Improved labeling for suitable traceability ■ Product number and batch number displayed on the biocontainer body ■ Users can fill in product batch information and more ■ High transparency film for easy visual inspection of the solution *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Uses】 ■ Preparation and storage of cell culture media ■ Preparation and storage of buffers ■ Harvesting after culture ■ Fraction recovery in chromatography processes ■ Fraction storage ■ Storage of intermediate products ■ Storage of product bulk before filling ■ Filling set ■ Sampling *For more details, please refer to the PDF document or feel free to contact us.
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.
